Cartalax
Cartalax
Bionk Peptides delivers high-performance research compounds engineered with uncompromising attention to detail. Every vial is produced to exceed 99% purity and supplied in lyophilised powder form, preserving molecular integrity while ensuring optimal stability and precision in application. Bionk Peptides are commitment to elevated research performance. For laboratory research only. Not for human use.
Couldn't load pickup availability
Description
Cartalax
Cartalax is a peptide complex studied in relation to connective-tissue processes. Within experimental and educational research, it is discussed in connection with models examining cartilage, extracellular matrix, and cells involved in maintaining tissue structure, including fibroblasts. Research may investigate its potential influence on specific cellular response markers and signalling pathways.
In laboratory research, Cartalax may be explored using in-vitro and preclinical models, with studies assessing parameters associated with tissue homeostasis, cellular proliferation, and the expression of selected signalling factors related to connective-tissue biology. It is also discussed in some experimental research concerning age-associated cellular processes, based on laboratory markers and model systems.
Laboratory Research Data Analysis
- Sequence: Ala-Glu-Asp (AED) tripeptide
- Molecular Formula: C₁₂H₁₉N₃O₈
- Molecular Weight: Approximately 333.29 g/mol
- Physical Form: Lyophilized (freeze-dried) solid powder, usually supplied in 20mg quantities
